Difference in outcomes following allogeneic hematopoietic cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndromes

Author:

Yanada Masamitsu1ORCID,Mizuno Shohei2,Yamasaki Satoshi3ORCID,Harada Kaito4ORCID,Konuma Takaaki5ORCID,Tamaki Hiroya6,Shingai Naoki7,Uchida Naoyuki8,Ozawa Yukiyasu9,Tanaka Masatsugu10,Onizuka Makoto4,Sawa Masashi11,Nakamae Hirohisa12,Shiratori Souichi13,Matsuoka Ken-ichi14,Eto Tetsuya15,Kawakita Toshiro16,Maruyama Yumiko17,Ichinohe Tatsuo18,Kanda Yoshinobu19,Atsuta Yoshiko2021,Aoki Jun22,Yano Shingo23

Affiliation:

1. Aichi Cancer Center, Nagoya, Japan

2. Aichi Medical University, Nagakute, Japan

3. Kyusyu University Beppu Hospital, Beppu, Japan

4. Tokai University School of Medicine, Isehara, Japan

5. The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

6. Hyogo College of Medicine, Nishinomiya, Japan

7. Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan

8. Toranomon Hospital, Tokyo, Japan

9. Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

10. Kanagawa Cancer Center, Yokohama, Japan

11. Anjo Kosei Hospital, Anjo, Japan

12. Graduate School of Medicine, Osaka City University, Osaka, Japan

13. Faculty of Medicine, Hokkaido University, Sapporo, Japan

14. Okayama University Hospital, Okayama, Japan

15. Hamanomachi Hospital, Fukuoka, Japan

16. National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan

17. Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

18. Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan

19. Jichi Medical University, Shimotsuke, Japan

20. Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan

21. Nagoya University Graduate School of Medicine, Nagoya, Japan

22. National Cancer Center Hospital, Tokyo, Japan

23. The Jikei University School of Medicine, Tokyo, Japan

Funder

Practical Research Project for Allergic Diseases and Immunology

Japan Agency for Medical Research and Development

Aichi Cancer Research Foundation

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3